Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Cold-chain integrity was solid
Are ferroptosis inducers effective in killing tumor cells in clinical therapy
Chan, and Ayako Kamimura
14.3 MOUNJARO Use in Combination with Metformin, Sulfonylureas, and/or SGLT2 Inhibitors in Adult Patients with Type 2 Diabetes Mellitus Add-on to metformin SURPASS-2 (NCT03987919) was a 40-week open-label trial (double-blind with respect to MOUNJARO dose assignment) that randomized 1879 adult patients with type 2 diabetes mellitus with inadequate glycemic control on stable doses of metformin alone to the addition of subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, or MOUNJARO 15 mg once weekly or subcutaneous semaglutide 1 mg once weekly
Clinical guidance on gastrointestinal effects of GLP-1 receptor agonists
US$ 24.59
US$ 24.61
US$ 25.48
US$ 21.98
US$ 23.11
US$ 22.58
US$ 28.88
US$ 29.95
